Total Funding
60
65
Total FundingPost-IPO Equity raised
Growth Score
-26 pts
Heat Score
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
249941
Genetic Technologies develops genetic risk assessment technology for breast cancer and colorectal cancer.
About the Company
Genetic Technologies is a biotechnology company specializing in predictive genetic testing for chronic diseases and cancers. Its services include risk assessments for conditions such as breast, colorectal, ovarian, pancreatic, and prostate cancers, as well as coronary artery disease, type 2 diabetes, melanoma, and atrial fibrillation. These
assessments integrate genetic data with clinical and familial information to provide personalized risk profiles.
